OAM
ELOS

Oxford Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Oxford Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-110,000
Closed -$1.21M – 1846
2017
Q2 		$1.21M Buy
+110,000
New +$1.21M 0.02% 823
2017
Q1 		– Sell
-63,795
Closed -$536K – 1548
2016
Q4 		$536K Buy
63,795
+48,426
+315% +$380K 0.02% 577
2016
Q3 		$110K Buy
+15,369
New +$107K ﹤0.01% 735
2015
Q4 		– Sell
-50,433
Closed -$361K – 1020
2015
Q3 		$361K Sell
50,433
-45,420
-47% -$436K 0.01% 533
2015
Q2 		$1.02M Sell
95,853
-81,441
-46% -$954K 0.03% 444
2015
Q1 		$2.19M Buy
+177,294
New +$1.96M 0.06% 343
2014
Q1 		– Sell
-38,698
Closed -$476K – 841
2013
Q4 		$476K Buy
+38,698
New +$402K 0.01% 593

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Oxford Asset Management's ELOS Position: Q3 2017 in Review

Oxford Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 110,000 shares — an estimated $1.21M sold.

Oxford Asset Management first reported a position in ELOS in Q4 2013 and held it in 7 quarters. The position peaked at $2.19M in Q1 2015. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Oxford Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Oxford Asset Management sold 110,000 Syneron Medical Ltd shares in Q3 2017, an estimated $1.21M.
  • Oxford Asset Management first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 7 quarters.
  • Oxford Asset Management's Syneron Medical Ltd position peaked at $2.19M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Oxford Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.